Market-Moving News for May 14th

SEPN: 82% | Septerna shares are trading higher after the company announced an exclusive global collaboration and license agreement with Novo Nordisk to develop oral small molecule medicines for obesity, type 2 diabetes, and other cardiometabolic diseases.

SMCI: 14% | SMCI Stock In 'Sweet Spot,' Says Raymond James — Sets $41 Price Target As AI Revenue Hits 70%

LUCY: 70% | Innovative Eyewear Q1 EPS $(0.72) Beats $(0.73) Estimate, Sales $454.50K Miss $1.00M Estimate